Serum NT‑proBNP and TUG1 as novel biomarkers for elderly hypertensive patients with heart failure with preserved ejection fraction
- Shuang Zhang
- Rize Jin
- Bi Li
Affiliations: Ultrasonic Department, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121000, P.R. China
- Published online on: March 1, 2021 https://doi.org/10.3892/etm.2021.9874
Copyright: © Zhang
et al. This is an open access article distributed under the
terms of Creative
Commons Attribution License.
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Patients with heart failure with preserved ejection fraction (HFPEF) account for ~50% of all cases of heart failure and their clinical prognosis is poor. The present study attempted to investigate the diagnostic value of circulating long non‑coding RNA taurine upregulated gene 1 (TUG1) for HFPEF in subjects with hypertension. Between January 2017 and January 2019, 80 aged/elderly hypertensive patients with or without HFPEF were recruited for the present study. The concentration of N‑terminal pro‑brain natriuretic peptide (NT‑proBNP) in the serum was measured using ELISA and TUG1 expression levels were determined using reverse transcription‑quantitative PCR. Echocardiography was used for the determination of cardiac function. The results indicated that the levels of NT‑proBNP and TUG1 were increased in the serum of hypertensive patients with HFPEF. Pearson analysis demonstrated that NT‑proBNP and TUG1 were positively correlated with the left atrial diameter and negatively correlated with the ratio of the peak flow velocity in the early diastolic phase to the peak flow velocity in the late diastolic phase. In addition, a positive correlation was confirmed between TUG1 and NT‑proBNP levels. Receiver operating characteristic curve analysis demonstrated that TUG1 and NT‑proBNP were useful biomarkers for the diagnosis of HFPEF. In conclusion, it was observed that NT‑proBNP and TUG1 were increased in the serum of hypertensive patients with HFPEF. Furthermore, TUG1 and NT‑proBNP were indicated to be useful plasma biomarkers for the diagnosis of HFPEF.